Internal Medicine, Rheumatology · Grand Rapids, MI
NPI
1184979577
Since 2012
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3271 Clear Vista Ct NE
Grand Rapids, MI, 49525
Phone (616) 267-7293
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
727 services
Medicare patients, 2024
197
Average age 70
Drug cost, 2024
$5.5M
5,629 prescriptions
Company payments, 2025
$21K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Barakat A Thabet was code 99214 (office e&m - established), 219 times for 151 patients. In total Barakat A Thabet billed 727 services in 13 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 219 | 151 | $66.42 | $15K |
| 99204 Office E&M - New | Office | 46 | 46 | $97.71 | $4,495 |
| 20610 Joint Injection | Office | 37 | 21 | $30.50 | $1,129 |
By year: 2022 $50K for 4,210 services; 2023 $42K for 3,101 services; 2024 $23K for 727 services.
Medicare prescription drug claims, 2024
In 2024, the drug Barakat A Thabet prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,124 prescriptions and refills. In total Barakat A Thabet wrote 5,629 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,124 | 3,046 | 365 | $78K |
| Prednisone Generic | 836 | 1,732 | 310 | $7,456 |
| Methotrexate Methotrexate Sodium | 753 | 1,620 | 219 | $26K |
| Folic Acid Generic | 247 | 727 | 83 | $1,658 |
| Leflunomide Generic | 244 | 553 | 76 | $18K |
| Enbrel Sureclick Etanercept | 183 | 191 | 31 | $1.4M |
| Humira(Cf) Pen Adalimumab | 180 | 191 | 25 | $1.3M |
| Sulfasalazine Generic | 127 | 298 | 40 | $5,957 |
| Alendronate Sodium Generic | 96 | 199 | 27 | $984 |
| Rinvoq Upadacitinib | 90 | 96 | 11 | $598K |
| Pantoprazole Sodium Generic | 89 | 238 | 27 | $1,180 |
| Sulfasalazine Dr Sulfasalazine | 77 | 146 | 21 | $3,833 |
| Allopurinol Generic | 76 | 196 | 21 | $784 |
| Methylprednisolone Generic | 74 | 90 | 46 | $810 |
| Leucovorin Calcium Generic | 72 | 176 | 20 | $1,111 |
Brand drugs: 1,095 claims; generic drugs: 4,465 claims; opioid claims: 144.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Barakat A Thabet $21K ($21K in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $17K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 47 | $17K |
| Janssen Biotech, Inc. JNJ | 6 | $2,452 |
| Amgen Inc. AMGN | 47 | $661 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $188 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $77.1 |
| UCB, Inc. UCB.BR | 3 | $67.17 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $60.47 |
| Organon LLC OGN | 5 | $59.38 |
| Pfizer Inc. PFE | 2 | $43.69 |
| Fresenius Kabi USA, LLC | 1 | $30.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.